Automation in oncology
In medicine – particularly in treating or operating on patients – robots still have their limitations. While they perform well in robotically assisted surgery, their use is still far from standard. This could be about to change, however, thanks to the SEON project at the University Hospital Erlangen, which is putting a Stäubli robot to use in oncology for the first time.
Up to now, most cancer patients have been prescribed surgery and/or chemotherapy. The latter is usually an arduous way for sufferers to fight tumors. This is because any chemotherapeutic course of treatment takes an immense toll on the body. The high-dose drugs necessary to fight cancer cells circulate through the body. In the process, they also affect healthy cells, weakening the patient.
The objective of the SEON research project is to open up completely new avenues for treating tumors through robotics. The idea is that solid tumors (metastases) would be precisely targeted as an alternative to chemo. For this purpose, the team in Erlangen has developed magnetic nanoparticles that serve as a means of transport for the drugs.
The robot chosen for this delicate mission is a large Stäubli TX200 six-axis robot equipped with a magnetic head. In a process called “magnetic drug targeting,” the magnetic head hovers over the patient’s body, directing the magnetic nanoparticles with the active ingredient directly to the tumor. Getting the theory to work in practice requires the efforts of physicians, mechanical engineers and robotics experts alike.
Stringent safety precautions incorporated into everyday hospital routines
Right from the start of the project, it became clear how crucial the pooling of expertise would be. Hospitals normally aim to bring in heavy equipment like X-ray machines or CT scanners at an early stage of construction, for example before the partiti